Richard D. Truesdell, Jr.

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering by Steelcase Inc. of $450 million principal…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 10,222,222 shares of common stock of…

Davis Polk advised the sole book-running manager of a $387.5 million SEC-registered offering of 5,000,000 shares of common stock of Alnylam Pharmaceuticals, Inc. Alnylam’s common stock is…

Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $5 billion aggregate principal amount of its $700 million aggregate principal…

Davis Polk advised the sole initial purchaser in connection with a Rule 144A offering by The Medicines Company of $150 million aggregate principal amount of 3.50% convertible senior…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of $300 million aggregate principal amount of floating-rate notes due 2022, …

Davis Polk advised Tyson Foods, Inc. in connection with its SEC-registered offerings of $900 million aggregate principal amount of senior notes in two series, consisting of $400 million…

Davis Polk advised the underwriter in connection with an SEC-registered secondary offering of 1,500,000 shares of Veritiv Corporation’s common stock by UWW Holdings, LLC. The common stock…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by AbbVie Inc. of $6 billion aggregate principal amount of senior notes in four…

Davis Polk advised the representatives of the several underwriters in connection with Galapagos NV’s offering of 2,961,373 ordinary shares in the form of American depositary shares, which…